Cargando…

Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction

The level of maladaptive myocardial remodeling consistently contributes to the poor prognosis of patients following a myocardial infarction (MI). In this study, we investigated whether and how sodium tanshinone IIA sulfonate (STS) would attenuate the post-infarct cardiac remodeling in mice model of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Shuai, Vincent, Matthew, Chen, Maosheng, Zhang, Minzhou, Hinek, Aleksander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639725/ https://www.ncbi.nlm.nih.gov/pubmed/31354493 http://dx.doi.org/10.3389/fphar.2019.00779

Ejemplares similares

Sodium tanshinone IIA sulfonate prevents the adverse left ventricular remodelling: Focus on polymorphonuclear neutrophil‐derived granule components
por: Mao, Shuai, et al.
Publicado: (2019)

Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia
por: Zhong, Liren, et al.
Publicado: (2020)

Tanshinone IIA Sodium Sulfonate Attenuates LPS-Induced Intestinal Injury in Mice
por: Yang, Xin-Jing, et al.
Publicado: (2018)

Corrigendum to “Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia”
por: Zhong, Liren, et al.
Publicado: (2020)

Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
por: Xu, Junyao, et al.
Publicado: (2019)

Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011)

Mechanism Study of the Protective Effects of Sodium Tanshinone IIA Sulfonate Against Atorvastatin-Induced Cerebral Hemorrhage in Zebrafish: Transcriptome Analysis
por: Zhou, Zhong-Yan, et al.
Publicado: (2020)

Sodium tanshinone IIA sulfonate stimulated Cl(−) secretion in mouse trachea
por: Chen, Peng-Xiao, et al.
Publicado: (2017)

Extracellular vesicle-derived circCEBPZOS attenuates postmyocardial infarction remodeling by promoting angiogenesis via the miR-1178-3p/PDPK1 axis
por: Yu, Ling, et al.
Publicado: (2023)

Sodium Tanshinone IIA Sulfonate Attenuates Scopolamine-Induced Cognitive Dysfunctions via Improving Cholinergic System
por: Xu, Qing-Qing, et al.
Publicado: (2016)

Sodium Tanshinone IIA Sulfonate Attenuates Tumor Oxidative Stress and Promotes Apoptosis in an Intermittent Hypoxia Mouse Model
por: Zhang, Xiao-Bin, et al.
Publicado: (2020)

Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling Pathway
por: Guan, Ruijuan, et al.
Publicado: (2018)

Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
por: Zhang, Rongjie, et al.
Publicado: (2022)

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension
por: Bao, Ya-Ru, et al.
Publicado: (2020)

Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro
por: Ouyang, Dong-sheng, et al.
Publicado: (2016)

Sodium tanshinone IIA sulfonate ameliorates cerebral ischemic injury through regulation of angiogenesis
por: Xu, Jiazhen, et al.
Publicado: (2021)

Tanshinone IIA: A Review of its Anticancer Effects
por: Fang, Zhong‐ying, et al.
Publicado: (2021)

Protective effects of tanshinone IIA sodium sulfonate on ischemia-reperfusion-induced myocardial injury in rats
por: Pan, Yun, et al.
Publicado: (2017)

Sodium tanshinone IIA sulfonate ameliorates neointima by protecting endothelial progenitor cells in diabetic mice
por: Heng, Yan-Yan, et al.
Publicado: (2023)

Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice Model
por: Lu, Lunjie, et al.
Publicado: (2016)

Sodium Tanshinone IIA Sulfonate Prevents Angiotensin II-Induced Differentiation of Human Atrial Fibroblasts into Myofibroblasts
por: Chen, Tangting, et al.
Publicado: (2018)

Sodium Tanshinone IIA Sulfonate Prevents Radiation-Induced Toxicity in H9c2 Cardiomyocytes
por: Zhang, Wenjing, et al.
Publicado: (2017)

Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment
por: Zheng, Yanfang, et al.
Publicado: (2022)

Tanshinone IIA alleviates atherosclerosis in LDLR(−/−) mice by regulating efferocytosis of macrophages
por: Wang, Jiarou, et al.
Publicado: (2023)

Sodium Tanshinone IIA Sulfonate Improves Hemodynamic Parameters, Cytokine Release, and Multi-Organ Damage in Endotoxemia Rabbits
por: Ma, Shaolei, et al.
Publicado: (2018)

Sodium tanshinone IIA sulfonate protects ARPE-19 cells against oxidative stress by inhibiting autophagy and apoptosis
por: Han, Dongmei, et al.
Publicado: (2018)

Sodium Tanshinone IIA Sulfonate Inhibits Vascular Endothelial Cell Pyroptosis via the AMPK Signaling Pathway in Atherosclerosis
por: Zhu, Ji, et al.
Publicado: (2022)

Traditional Chinese medicine, Danlou tablets alleviate adverse left ventricular remodeling after myocardial infarction: results of a double-blind, randomized, placebo-controlled, pilot study
por: Mao, Shuai, et al.
Publicado: (2016)

Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials
por: Kan, Zunqi, et al.
Publicado: (2023)

Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA
por: Zhong, Chenhui, et al.
Publicado: (2021)

Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats
por: Yan, Jun, et al.
Publicado: (2016)

Sodium tanshinone IIA sulfonate protects against Aβ‐induced cell toxicity through regulating Aβ process
por: Zhang, Da‐Peng, et al.
Publicado: (2020)

Tanshinone IIA attenuates heart failure via inhibiting oxidative stress in myocardial infarction rats
por: Chen, Ruijuan, et al.
Publicado: (2021)

Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats
por: HE, HUANYU, et al.
Publicado: (2015)

Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms
por: Zhu, Peng-Chong, et al.
Publicado: (2023)

Investigating Derivatives of Tanshinone IIA Sulfonate Sodium and Chloroxine for Their Inhibition Activities against the SARS-CoV-2 Papain-like Protease
por: Chen, Xin, et al.
Publicado: (2022)

Sodium Tanshinone II-A Sulfonate (DS-201) Induces Vasorelaxation of Rat Mesenteric Arteries via Inhibition of L-Type Ca(2+) Channel
por: Zhang, Xiao-Dong, et al.
Publicado: (2018)

The Vascular Effects of Sodium Tanshinone IIA Sulphonate in Rodent and Human Pregnancy
por: Morton, Jude S., et al.
Publicado: (2015)

Tanshinone IIA Improves Ventricular Remodeling following Cardiac Infarction by Regulating miR-205-3p
por: Qiao, Peng, et al.
Publicado: (2021)

Tanshinone IIA Suppresses Proliferation and Inflammatory Cytokine Production of Synovial Fibroblasts from Rheumatoid Arthritis Patients Induced by TNF-α and Attenuates the Inflammatory Response in AIA Mice
por: Du, Hongyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ehovinkr6it9o5n2fs2alr9i97